Stryker (SYK) Tops Q4 EPS by 1c, Offers Q1 and FY Guidance
Get Alerts SYK Hot Sheet
Price: $303.13 -1.58%
EPS Growth %: +12.2%
Financial Fact:
Net sales: 2.83B
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +12.2%
Financial Fact:
Net sales: 2.83B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Stryker (NYSE: SYK) reported Q4 EPS of $1.96, $0.01 better than the analyst estimate of $1.95. Revenue for the quarter came in at $3.5 billion versus the consensus estimate of $3.4 billion.
GUIDANCE:
Stryker sees Q1 2018 EPS of $1.57-$1.62, versus the consensus of $1.60.
Stryker sees FY2018 EPS of $7.07-$7.17, versus the consensus of $7.12.
- 2018 organic sales growth to be in the range of 6.0% to 6.5%
For earnings history and earnings-related data on Stryker (SYK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Ambarella (AMBA) Tops Q2 EPS by 1c; offers guidance
- UiPath Inc. (PATH) Reports In-Line Q2 EPS; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share